Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Press Release: Indian manufacturer cuts price of childhood vaccine by 30 percent

Gavi: The Vaccine Alliance

April 18, 2013

The cost of immunising millions of the world’s most vulnerable children against five deadly and debilitating diseases is set to fall, thanks to a major price reduction of one third for pentavalent vaccine.

This new, more cost-effective price provides the opportunity for the GAVI Alliance to pay up to US$ 150 million less over the next four years compared with using lowest cost alternative suppliers.

A supply agreement with Biological E Ltd of India makes the five-in-one shot available to GAVI for just $1.19 per dose, compared to the 2012 weighted average price of $2.17.

Read the full text here.